0001209191-15-057918.txt : 20150701 0001209191-15-057918.hdr.sgml : 20150701 20150701160942 ACCESSION NUMBER: 0001209191-15-057918 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150629 FILED AS OF DATE: 20150701 DATE AS OF CHANGE: 20150701 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NEKTAR THERAPEUTICS CENTRAL INDEX KEY: 0000906709 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943134940 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 455 MISSION BAY BOULEVARD SOUTH CITY: SAN FRANCISCO STATE: CA ZIP: 94158 BUSINESS PHONE: 4154825300 MAIL ADDRESS: STREET 1: 455 MISSION BAY BOULEVARD SOUTH CITY: SAN FRANCISCO STATE: CA ZIP: 94158 FORMER COMPANY: FORMER CONFORMED NAME: INHALE THERAPEUTIC SYSTEMS INC DATE OF NAME CHANGE: 19980723 FORMER COMPANY: FORMER CONFORMED NAME: INHALE THERAPEUTIC SYSTEMS DATE OF NAME CHANGE: 19940303 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: WANG SUSAN CENTRAL INDEX KEY: 0001246409 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-24006 FILM NUMBER: 15965167 MAIL ADDRESS: STREET 1: 40919 ENCYCLOPEDIA CIRCLE CITY: FREMONT STATE: CA ZIP: 94538 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2015-06-29 0 0000906709 NEKTAR THERAPEUTICS NKTR 0001246409 WANG SUSAN C/O NEKTAR THERAPEUTICS 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 1 0 0 0 Common Stock 2015-06-29 4 M 0 15000 8.81 A 35000 D Common Stock 2015-06-29 4 S 0 15000 12.70 D 20000 D Common Stock 2015-06-29 4 M 0 15000 5.15 A 35000 D Common Stock 2015-06-29 4 S 0 15000 12.70 D 20000 D Stock Option 8.81 2015-06-29 4 M 0 15000 0.00 D 2008-09-19 2015-09-18 Common Stock 15000 0 D Stock Option 5.15 2015-06-29 4 M 0 15000 0.00 D 2009-09-30 2016-12-01 Common Stock 15000 0 D This transaction was made pursuant to a Rule 10b5-1 trading plan. This transaction was executed in multiple trades at prices ranging from $12.58 to $12.81. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer. Gilbert M. Labrucherie, Jr., Attorney-in-Fact 2015-07-01